Related Experiment Video
Updated: Aug 6, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Autophagy signaling and the cogwheels of cancer
Joëlle Botti1, Mojgan Djavaheri-Mergny, Yannick Pilatte
1INSERM U756, Faculté de Pharmacie, Université Paris-Sud, 92296 Châtenay-Malabry, France.
Abstract:
The downregulation of macroautophagy observed in cancer cells is associated with tumor progression. The regulation of macroautophagy by signaling pathways overlaps with the control of cell growth, proliferation, cell survival and death. Several tumor suppressor genes (PTEN, TSC2 and p53) involved in the mTOR signaling network have been shown to stimulate autophagy. In contrast, the oncoproteins involved in this network have the opposite effect. These findings, together with the discovery that haploinsufficiency of the tumor suppressor beclin 1 promotes tumorigenesis in various tissues in transgenic mice, give credibility to the idea that autophagy is a tumor suppressor mechanism. The induction of macroautophagy by cancer treatments may also contribute to cell eradication. However, cancer cells sometimes mobilize autophagic capacities in response to various stimuli without a fatal outcome, suggesting that they can also exploit macroautophagy for their own benefit.
Insights
Macroautophagy, a cellular process, acts as a tumor suppressor by inhibiting cancer progression. However, cancer cells can also utilize macroautophagy for survival, complicating its role in cancer treatment.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- Macroautophagy (a cellular degradation process) is often downregulated in cancer cells, correlating with tumor progression.
- Signaling pathways regulating macroautophagy are intertwined with critical cellular processes like growth, proliferation, survival, and death.
- Tumor suppressor genes (e.g., PTEN, TSC2, p53) within the mTOR network promote autophagy, while oncoproteins inhibit it.
Purpose of the Study:
- To investigate the dual role of macroautophagy in cancer, examining its potential as a tumor suppressor mechanism and its exploitation by cancer cells.
- To explore the relationship between macroautophagy regulation, signaling pathways, and tumorigenesis.
- To understand how cancer treatments that induce macroautophagy impact cancer cell eradication versus survival.
Main Methods:
- Review of existing literature on macroautophagy, signaling pathways (e.g., mTOR), tumor suppressor genes, and oncoproteins in cancer.
- Analysis of findings from studies involving transgenic mice and cancer treatment responses.
- Correlation analysis between macroautophagy levels, gene expression (tumor suppressors vs. oncoproteins), and tumor progression/treatment outcomes.
Main Results:
- Downregulation of macroautophagy is linked to tumor progression.
- Tumor suppressor genes stimulate autophagy, supporting its role as a tumor suppressor mechanism.
- Haploinsufficiency of tumor suppressor beclin 1 promotes tumorigenesis.
- Cancer cells can exploit macroautophagy for survival, even under therapeutic pressure.
Conclusions:
- Macroautophagy functions as a tumor suppressor mechanism, with its downregulation contributing to cancer development.
- The interplay between signaling pathways and macroautophagy highlights its complex role in cell fate.
- Cancer cells can adapt to utilize macroautophagy for survival, presenting a challenge for cancer therapies aiming to induce cell death via this pathway.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

